BD Care Coordination Engine (CCE) Infusion Adapter, Safety Management Software Recall
BD Care Coordination Engine (CCE) Infusion Adapter, Safety Management Software
FDA recall Class I
Ongoing
FDA lists this Class I recall for BD Care Coordination Engine (CCE) Infusion Adapter, Safety Management Software. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-1305-2025
- Recall classification
- Class I
- Enforcement status
- Ongoing
- Initiation date
- Feb 18, 2025
- FDA report date
- Mar 19, 2025
- Quantity in commerce
- Not reported
- Distribution
- See key details
- FDA cause
- Under Investigation by firm
What is being recalled?
BD Care Coordination Engine (CCE) Infusion Adapter, Safety Management Software
Affected model & UDI checker
Search the exact identifiers published for Z-1305-2025.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | BD Care Coordination Engine (CCE) Infusion Adapter, Safety Management Software | Check source notice | 10885403510472 |
FDA code information
Software: v1.7.2/UDI: 10885403510472
Why was this product recalled?
Software issue that may result in outdated automated programming request(APR) being sent to the progressive care unit (PCU).
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did CareFusion 303, Inc. take?
On February 18, 2025, Becton, Dickinson issued a " Urgent Medical Device Product Correction" Notification. to affected consignees via Fed-Ex and E-Mail. 1. Users should review all infusion parameters pre-populated and confirm they are correct before pressing START as stated in the BD Alaris User Manual. 2. Disseminate this notice within your facility network to ensure that all concerned personnel are made aware of this issue. 3. BD Project Managers will engage with you to address any questions regarding this notice, and specific next steps for your facility. 4. Complete the attached Customer Response Form and return to the BD contact noted on the form, regardless of whether you have any of the impacted material. This will allow BD to confirm receipt of this notification. 5. Report any adverse health consequences experienced with the use of this product to BD. Events may also be reported to the FDA's MedWatch Adverse Event Reporting program.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-1305-2025
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 22, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 22, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology